BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Galectin Therapeutics Announces Update on Warrant Exercises

  August 28, 2013

   · 

  1 min read
• BioMidwest

  Sigma-Aldrich Corporation Release: BioReliance® Introduces Updated Big Blue® Mouse Assay Service

  August 28, 2013

   · 

  5 min read
• Biotech Bay

  Ultragenyx Pharmaceuticals Announces Presentation of Three Abstracts at the 12th International Congress of Inborn Errors of Metabolism (ICIEM 2013)

  August 28, 2013

   · 

  1 min read
• Immucor to Host Debt Investor Conference Call on Wednesday, September 4, 2013

  August 28, 2013

   · 

  1 min read
• BioMidwest

  Vomaris Releases New Retrospective Study Conclusions

  August 28, 2013

   · 

  3 min read
• Drug Development

  Orexo AB Reports Successful Completion of OX51 Phase II Dose-Finding Study in Prevention of Procedure-Induced Pain

  August 28, 2013

   · 

  1 min read
• Drug Development

  Catabasis Pharmaceuticals, Inc. to Present Phase 1 Data From Oral SMART Linker Conjugate CAT-2003 at Upcoming Conference

  August 28, 2013

   · 

  2 min read
• Drug Development

  Can-Fite BioPharma to Initiate a Phase II Study With CF102 in 130 Patients With Advanced Liver Cancer

  August 28, 2013

   · 

  4 min read
• Biotech Bay

  BioTime Receives Approval to Begin Human Clinical Trials of Renevia

  August 28, 2013

   · 

  1 min read
• Drug Development

  Acucela Inc. Reaches 50% Enrollment in the Emixustat Hydrochloride Phase 2b/3 Clinical Trial

  August 28, 2013

   · 

  1 min read